Nearly half of adult women experience urinary incontinence, yet fewer than 40% seek medical care for this treatable condition. The reluctance stems from embarrassment, cultural taboos, and the mistaken belief that bladder control issues are an inevitable part of aging. This diagnostic gap represents a significant quality-of-life burden that automated screening protocols may finally address. The JAMA Internal Medicine study demonstrates that systematic screening in primary care settings significantly increases both diagnosis rates and treatment initiation compared to standard care approaches. The intervention involved automated questionnaires integrated into routine visits, combined with provider education modules about evidence-based treatment options. Women in the screening group were 40% more likely to receive a formal diagnosis and nearly twice as likely to begin treatment within six months. The automated system identified cases across all age groups, with particularly notable increases among younger women who traditionally underreport symptoms. From a clinical implementation perspective, this represents a scalable solution that addresses healthcare's persistent blind spots around women's pelvic health. The approach tackles both patient reluctance to discuss symptoms and provider inconsistency in addressing them. However, the study's six-month follow-up period limits understanding of long-term treatment adherence and symptom resolution. The research also focused primarily on initial diagnosis rather than treatment effectiveness or patient satisfaction outcomes. While promising for improving care access, the real measure of success will be whether automated screening translates into sustained symptom improvement and enhanced quality of life for the millions of women affected by this underdiagnosed condition.